Therapeutic Asset Ratings
461 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ARRY-558
Colorectal Neoplasm
Pfizer
P1
C
(39)
Calcium folinate pentahydrate
Glioma
Pfizer
P1
C
(39)
Claturafenib
Advanced or Metastatic Solid Tumors
Pfizer
P1
C
(39)
Claturafenib
Glioma
Pfizer
P1
C
(39)
Eloxatin
Glioma
Pfizer
P1
C
(39)
FLUOROURACILUM
Glioma
Pfizer
P1
C
(39)
Irinotecan
Advanced or Metastatic Solid Tumors
Pfizer
P1
C
(39)
Lotiglipron
Type 2 Diabetes Mellitus
Pfizer
P1
C
(39)
MIDAZOLAM
Glioma
Pfizer
P1
C
(39)
pf-06954522
Obesity Disorder
Pfizer
P1
C
(39)
pf-07224826
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(39)
pf-07257876
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(39)
pf-07257876
Ovarian Cancer
Pfizer
P1
C
(39)
pf-07260437
Ovarian Neoplasm
Pfizer
P1
C
(39)
pf-07263689
Urinary Bladder Carcinoma
Pfizer
P1
C
(39)
pf-07263689
Head And Neck Cancer
Pfizer
P1
C
(39)
pf-07263689
Sarcoma
Pfizer
P1
C
(39)
pf-07329640
Advanced or Metastatic Solid Tumors
Pfizer
P1
C
(39)
pf-07799544
Advanced or Metastatic Solid Tumors
Pfizer
P1
C
(39)
pf-07799544
Glioma
Pfizer
P1
C
(39)
pf-07820435
Colorectal Carcinoma
Pfizer
P1
C
(39)
pf-07820435
Urothelial Carcinoma
Pfizer
P1
C
(39)
pf-07826390
Colorectal Carcinoma
Pfizer
P1
C
(39)
pf-07921585
Urinary Bladder Carcinoma
Pfizer
P1
C
(39)
pf-07921585
Head And Neck Cancer
Pfizer
P1
C
(39)
Showing 351 to 375 of 461 assets
Previous
Page 15 of 19
Next
